Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

Latest from the CoBRIM study

Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia

Latest from the CoBRIM study ( Prof Grant McArthur - Peter MacCallum Cancer Centre, Melbourne, Australia )

Anti-PD-1 or anti-CTLA-4 in first line therapy?

Prof Claus Garbe - University of Tübingen, Tübingen, Germany

Anti-PD-1 or anti-CTLA-4 in first line therapy? ( Prof Claus Garbe - University of Tübingen, Tübingen, Germany )

Long response and long responders in melanoma immunology

Prof Georgina Long - University of Sydney, Sydney, Australia

Long response and long responders in melanoma immunology ( Prof Georgina Long - University of Sydney, Sydney, Australia )

The Co-BRIM study: Quality-of-life assessment in patients with metastatic...

Prof Brigitte Dreno - Nantes University Hospital, Nantes, France

The Co-BRIM study: Quality-of-life assessment in patients with metastatic melanoma ( Prof Brigitte Dreno - Nantes University Hospital, Nantes, France )

Benefit and risk analysis from the phase III OPTiM trial

Dr Kevin Harrington - Institute of Cancer Research, London, UK

Benefit and risk analysis from the phase III OPTiM trial ( Dr Kevin Harrington - Institute of Cancer Research, London, UK )

Progress in targeted therapy of melanoma

Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA

Progress in targeted therapy of melanoma ( Prof Keith Flaherty - Massachusetts General Hospital, Boston, USA )

Melanoma prevention: Do we need sunlight for vitamin D?

Prof Julia A Newton-Bishop - University of Leeds, Leeds, UK

Melanoma prevention: Do we need sunlight for vitamin D? ( Prof Julia A Newton-Bishop - University of Leeds, Leeds, UK )

Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study

Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany

Metastatic melanoma: Patient-reported outcomes from the KEYNOTE-002 study ( Prof Dirk Schadendorf - University of Duisburg-Essen, Essen, Germany )

Why is screening for melanoma important?

Prof Iris Zalaudek - Medical University of Graz, Graz, Austria

Why is screening for melanoma important? ( Prof Iris Zalaudek - Medical University of Graz, Graz, Austria )

Management of acute metastatic melanoma

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK

Management of acute metastatic melanoma ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )

How should we handle talimogene laherparepvec (T-VEC)?

Prof Axel Hauschild - University of Kiel, Kiel, Germany

How should we handle talimogene laherparepvec (T-VEC)? ( Prof Axel Hauschild - University of Kiel, Kiel, Germany )

New challenges in drug combination and strategies

Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK

New challenges in drug combination and strategies ( Dr Paul Lorigan - The Christie NHS Foundation Trust, Manchester, UK )

More from ecancer